Phase I Trial of PX-478

Clinical trial NCT00522652 · COMPLETED

Trial details

NCT number: NCT00522652
Sponsor: Cascadian Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Lymphoma

Start date: 2007-08-01
Primary completion: 2010-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.